Multiplex gene‐panel testing for lung cancer patients

Volume: 70, Issue: 12, Pages: 921 - 931
Published: Sep 21, 2020
Abstract
The year 2019 was considered to be the first year of cancer genome medicine in Japan, with three gene-panel tests using next-generation sequencing (NGS) techniques being introduced into clinical practice. Among the three tests, the Oncomine CDx Target test was approved under the category of regular molecular testing for lung cancer, which meant that this test could be used to select patients for molecularly targeted drugs. Conversely, the other...
Paper Details
Title
Multiplex gene‐panel testing for lung cancer patients
Published Date
Sep 21, 2020
Volume
70
Issue
12
Pages
921 - 931
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.